Revvity Inc. 超过收入预测,报告强劲的销售增长,并更新全年指导。 Revvity Inc. exceeds earnings forecasts, reports strong sales growth, and updates full-year guidance.

生命科学公司Revvity Inc.报告第二季度收入5 390万美元,即每股46美分,收入7.203亿美元,超过预测。 Revvity Inc., a life sciences company, reported second-quarter earnings of $53.9 million, or 46 cents per share, and revenue of $720.3 million, exceeding forecasts. 该公司将其全年收入指导提高到28.4亿至28.8亿美元之间,经调整的EPS指导为每股4.85至4.95美元。 The company raised its full-year revenue guidance to between $2.84 billion and $2.88 billion, with adjusted EPS guidance of $4.85 to $4.95 per share. 复苏注意到销售年同比增长4.1%,全年调整的EPS指南略有下降。 Revvity noted a 4.1% year-over-year increase in sales and a slight decrease in full-year Adjusted EPS guidance.